Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$63,118 | -$69,197 | -$88,098 | -$98,591 |
| Dep. & Amort. | $1,781 | $1,854 | $1,666 | $1,193 |
| Deferred Tax | $0 | $0 | $0 | $2,762 |
| Stock-Based Comp. | $7,407 | $9,223 | $9,576 | $8,500 |
| Change in WC | -$8,440 | -$9,864 | -$3,057 | $20,507 |
| Other Non-Cash | $1,081 | -$1,541 | $3,409 | $8,563 |
| Operating Cash Flow | -$61,289 | -$69,525 | -$76,504 | -$57,066 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$41 | -$206 | -$1,953 | -$2,338 |
| Net Acquisitions | $148 | $0 | -$59,815 | $229,863 |
| Inv. Purchases | -$88,855 | -$164,988 | -$180,704 | -$313,375 |
| Inv. Sales/Matur. | $146,324 | $236,232 | $240,519 | $83,512 |
| Other Inv. Act. | $0 | $0 | $59,815 | -$229,863 |
| Investing Cash Flow | $57,576 | $71,038 | $57,862 | -$232,201 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $108 | $253 | $503 | $259,206 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $51,902 |
| Financing Cash Flow | $108 | $253 | $503 | $311,108 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,605 | $1,766 | -$18,139 | $21,841 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,575 | $10,809 | $28,948 | $7,107 |
| End Cash | $8,970 | $12,575 | $10,809 | $28,948 |
| Free Cash Flow | -$61,330 | -$69,731 | -$78,457 | -$59,404 |